Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC5227 Triazophos
EC 3.1.1.7 (Acetylcholinesterase) inhibitor, acting as an insecticide, an acaricide, an agrochemical, and a nematicide
More description
DCC5226 Trenbolone Enanthate
Potent and long-acting derivative of the hormone Trenbolone
More description
DCC5225 Trehalose-6-phosphate
Central sugar signal in plants, regulating sucrose use and allocation, underpinning crop growth and development
More description
DCC5224 Trc210258
Novel TGR5 agonist, reducing glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
More description
DCC5223 trapoxin B
Inhibitor of histone deacetylases
More description
DCC5222 Trantinterol
Novel Highly Selective β2-Adrenoceptor Agonist as an Oral Antiasthmatic Agent
More description
DCC5221 trans-resveratrol-4'-o-glucuronide
Metabolite of Resveratrol
More description
DCC5220 trans-resveratrol-3-o-glucuronide
Metabolite of Resveratrol
More description
DCC5219 Trans-ocma
Natural specific inhibitor of γ-secretase, decreasing amyloid-beta levels without influencing cleavage of Notch, showing strong growth inhibitory effects on cancer cell lines and significant anti-complement activity, also acting as a PTP1B inhibitor
More description
DCC5218 Trans-miyabenol C
Natural resveratrol trimer, acting as a protein kinase C inhibitor
More description
DCC5217 Trans-cbtbp
Novel KGA allosteric inhibitor
More description
DCC5216 Trans-bopc1
Novel HuR binder, modulating HuR-RNA interactions
More description
DCC5215 Trans-abcd
Potent and selective NMDA agonist
More description
DCC5214 Trans- Resveratrol-4’-sulfate Sodium Salt
Metabolite of Resveratrol
More description
DCC5213 Tracizoline
Potent I 2 -imidazoline receptor agonist
More description
DCC5212 Tp-s1-68
Novel Type-I Inhibitor of TIE-2
More description
DCC5211 Tpp-cl2
Mitochondria-activatable luciferin (MAL-Probe)
More description
DCC5210 Tpmp-i-2
Enhancer of the cytotoxic effect of immunotoxins (ITs) which results in increased apoptosis in different cancer cells
More description
DCC5209 Tpl2-in-i
Novel tumour progression locus 2 (Tpl2) kinase inhibitor
More description
DCC5208 Tpi-287
Novel taxane family member, reducing the brain metastatic colonization of breast cancer cells
More description
DCC5207 Tpi-2659-17
Novel Specific Inhibitor of Type I Collagen Production in Fibrosis
More description
DCC5206 Tpi-1917-49
Promising amyloid reducing agent by lowering the levels of Aβ.
More description
DCC5205 Tpi1609-10
Inhibitor of tyrosine recombinases and Holliday junction-resolving enzymes; Antibacterial
More description
DCC5204 Tph1-in-23a
Novel Peripheral Selective Tryptophan Hydroxylase 1 (TPH1) Inhibitor (IC 50 : 42nM) for Obesity and Fatty Liver Disease
More description
DCC5203 Tpe-gal
First-in-class fluorescent drug delivery vesicle that can efficiently load both water-soluble and -insoluble anticancer drugs
More description
DCC5202 Tp-238 Hydrochloride
Novel probe for CECR2/BPTF bromodomains
More description
DCC5201 Tp-040
Novel inhibitor of O-GlcNAcase (OGA)
More description
DCC5200 Tp-008
Novel probe for activin receptor-like kinase (ALK4 and ALK5)
More description
DCC5199 Toxt-in-8
Novel ToxT inhibitor, reducing Vibrio cholerae virulence in vivo and effectively inhibiting intestinal colonization in the infant mouse
More description
DCC5198 Tosylaniline
Selective CA IX inhibitor
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X